本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Denali Therapeutics Inc.

20.06
-0.3200-1.57%
盤後20.060.00000.00%19:30 EDT
成交量:185.56萬
成交額:3,741.88萬
市值:32.07億
市盈率:-7.07
高:20.51
開:20.40
低:19.87
收:20.38
52周最高:27.30
52周最低:12.58
股本:1.60億
流通股本:1.51億
量比:1.29
換手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
淨資產收益率:-54.93%
總資產收益率:-29.15%
市淨率:3.84
市盈率(LYR):-6.75

資料載入中...

2023/10/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/09/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/21

重要事件披露

Form 8-K - Current report
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/08

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities